Literature DB >> 16139031

Gastric motility, gastroparesis, and gastric stimulation.

Brian E Lacy1, Kirsten Weiser.   

Abstract

Gastroparesis is the most common disorder of gastric motility. It is frequently overlooked in clinical practice because the symptoms of gastroparesis are nonspecific. This article reviews normal and abnormal gastric motility, discusses the etiology and pathogenesis of gastroparesis, and provides an overview on new treatment options for gastroparesis, including gastric stimulation.

Entities:  

Mesh：

Year:  2005        PMID： 16139031     DOI： 10.1016/j.suc.2005.05.005

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  9 in total

Review 1.  An update on autonomic neuropathy affecting the gastrointestinal tract.

Authors:  Liza K Phillips; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

2.  Alterations of Gastric Emptying Features Following Laparoscopic Sleeve Gastrectomy in Chinese Patients with Obesity: a Self-Controlled Observational Study.

Authors:  Mengyi Li; Yang Liu; Lan Jin; Wei Wang; Na Zeng; Lixue Wang; Kaixin Zhao; Wei Xu; Zhongtao Zhang; Jigang Yang
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

Review 3.  Endoscopic botox injections in therapy of refractory gastroparesis.

Authors:  Andrew Ukleja; Kanwarpreet Tandon; Kinchit Shah; Alicia Alvarez
Journal:  World J Gastrointest Endosc       Date:  2015-07-10

4.  Water Tolerance After Laparoscopic Sleeve Gastrectomy.

Authors:  Athar S Elward; Ibrahim G Khalifa; Mohamed H Fahmy; Hany A Samy; Ahmed A S Al-Attar
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

5.  Sepiapterin reverses the changes in gastric nNOS dimerization and function in diabetic gastroparesis.

Authors:  P R R Gangula; S Mukhopadhyay; P J Pasricha; K Ravella
Journal:  Neurogastroenterol Motil       Date:  2010-08-22       Impact factor: 3.598

6.  Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?

Authors:  Brian E Lacy; Kirsten Weiser; Abigail Kennedy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-04

Review 7.  Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature.

Authors:  Emma M Tillman; Keaton S Smetana; Likeselam Bantu; Merrion G Buckley
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Mar-Apr

8.  Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects.

Authors:  Italo Braghetto; Cristóbal Davanzo; Owen Korn; Attila Csendes; Héctor Valladares; Eduardo Herrera; Patricio Gonzalez; Karin Papapietro
Journal:  Obes Surg       Date:  2009-08-28       Impact factor: 4.129

9.  Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.

Authors:  Michael Camilleri; Richard W McCallum; Jan Tack; Sharon C Spence; Keith Gottesdiener; Fred T Fiedorek
Journal:  Gastroenterology       Date:  2017-07-29       Impact factor: 22.682
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.